{"name":"Sinovac (Dalian) Vaccine Technology Co., Ltd.","slug":"sinovac-dalian-vaccine-technology-co-ltd","ticker":"","exchange":"","domain":"sinovacdalianvaccinetechnology.com","description":"Sinovac Biotech Ltd. is a Chinese biopharmaceutical company based in Haidian District, Beijing that focuses on the research, development, manufacture, and commercialization of vaccines that protect against human infectious diseases. The company was listed on the Nasdaq but the exchange halted Sinovac's trading in February 2019 due to a proxy fight. The company has faced bribery probes in China. Its COVID-19 vaccine was the target of a covert disinformation campaign by the US government and a promotional social media astroturfing campaign by the Chinese government.","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"Varicella vaccine+TIV","genericName":"Varicella vaccine+TIV","slug":"varicella-vaccine-tiv","indication":"Prevention of varicella (chickenpox)","status":"marketed"},{"name":"Investigational live attenuated varicella vaccine","genericName":"Investigational live attenuated varicella vaccine","slug":"investigational-live-attenuated-varicella-vaccine","indication":"Other","status":"marketed"},{"name":"PROVARIX","genericName":"PROVARIX","slug":"provarix","indication":"Prevention of herpes zoster (shingles) in adults aged 50 years and older","status":"phase_3"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"immunology","drugs":[{"name":"Vaccine manufactured at commercialized scale","genericName":"Vaccine manufactured at commercialized scale","slug":"vaccine-manufactured-at-commercialized-scale","indication":"COVID-19 prevention","status":"phase_3"},{"name":"Mumps vaccine","genericName":"Mumps vaccine","slug":"mumps-vaccine","indication":"Prevention of mumps infection in children and adults","status":"marketed"}]}],"pipeline":[{"name":"Varicella vaccine+TIV","genericName":"Varicella vaccine+TIV","slug":"varicella-vaccine-tiv","phase":"marketed","mechanism":"This combination vaccine stimulates immune responses against varicella-zoster virus and influenza virus through live attenuated or inactivated viral antigens.","indications":["Prevention of varicella (chickenpox)","Prevention of seasonal influenza"],"catalyst":""},{"name":"Investigational live attenuated varicella vaccine","genericName":"Investigational live attenuated varicella vaccine","slug":"investigational-live-attenuated-varicella-vaccine","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"PROVARIX","genericName":"PROVARIX","slug":"provarix","phase":"phase_3","mechanism":"PROVARIX is a recombinant varicella-zoster virus (VZV) vaccine designed to prevent herpes zoster (shingles) and post-herpetic neuralgia in immunocompetent and immunocompromised populations.","indications":["Prevention of herpes zoster (shingles) in adults aged 50 years and older","Prevention of post-herpetic neuralgia in adults aged 50 years and older"],"catalyst":""},{"name":"Vaccine manufactured at commercialized scale","genericName":"Vaccine manufactured at commercialized scale","slug":"vaccine-manufactured-at-commercialized-scale","phase":"phase_3","mechanism":"This vaccine works by stimulating the body's immune system to produce a protective response against the SARS-CoV-2 virus.","indications":["COVID-19 prevention"],"catalyst":""},{"name":"Mumps vaccine","genericName":"Mumps vaccine","slug":"mumps-vaccine","phase":"marketed","mechanism":"The mumps vaccine stimulates the immune system to produce antibodies and cellular immunity against the mumps virus, preventing infection and disease.","indications":["Prevention of mumps infection in children and adults"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxOUFlNSVFWUlNxVnIzcEdpSWRxeEN0OVBNSFNyc29reVBHcnFRTG1DbXJ5eWRHVzV3SkNTblhKYWdmV0toYzN4YU9zZWVvY3JQVUxGcWlTSmhVVmd2a3k4UWk4d0tZWDNSbTR4WC1uTklyLWdCZmYtaVRzTE9xVzFZTGVFZFhjbDI1U2JZcDE5eXNJUUJEbjB3NUlxZw?oc=5","date":"2026-04-07","type":"pipeline","source":"openPR.com","summary":"Herpes Zoster Treatment Market Size in the 7MM is projected - openPR.com","headline":"Herpes Zoster Treatment Market Size in the 7MM is projected","sentiment":"neutral"}],"patents":[],"drugCount":5,"phaseCounts":{"marketed":3,"phase_3":2},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}